BIOADAPTIVES INC
2 traders squawked $BDPT this week
Company and security reference data from OTC Markets Group.
$BDPT in the top 20 dollar volume under .01 this morning. At .0035 with 91,958,125 o/s the market cap is $322k. There HAS been steady dilution. Im watching and have IRA run a full DD dive.
DD entries are user-generated due diligence, not investment advice. Moderated. Filings link to sec.gov.
$BDPT got some news today and otcmarkets SS updates with no changes
$BDPT the insider filing notification was QUICK! @TophatTopher
$BDPT has a UFC connection
The OTC Heat Map picked up on $BDPT yesterday. Im currently up 30% on it.
$BDPT (Bioadaptives, Inc.) — Recently ~$0.002–$0.0035 with tens of millions in share volume. Recent updates include retiring debt from a major convertible investor (removing overhang), scaling e-commerce for the MyndSystem nootropic platform, operational readiness for product launches, and details on the Xcellara stem-cell-related wellness platform (including a cardiovascular formula claiming clinical data). These press releases appeared in late July. otcmarkets.com
No level shown - preferred stock disclosures and convertible note disclosures could not be read reliably from this filing. The extracted facts are below.
From 10-Q filed May 15, 2026View filing
Level = disclosed potential new shares (warrants + preferred conversion shares + shares issuable from convertible notes, where the filing states them) divided by shares outstanding:
under 10% = Low · 10-50% = Moderate · 50-200% = Elevated · over 200% = Substantial
Only figures stated explicitly in the filing are used - nothing is estimated. A level is shown only when the share count was read with high confidence AND each of convertibles, warrants, and preferred stock was either clearly disclosed or affirmatively stated as none by the filing. If any of the three could not be read reliably, no level is shown at all - partial data never produces a label. Authorized headroom is shown as a separate fact and is not part of the level. Convertible note principal (dollars) is never converted into shares.
Figures are AI-extracted from the company's own SEC filings and may contain errors - always verify against the linked filing. This is not investment advice.
